Post-treatment PSA =<0.2 ng/ml defines disease freedom after radiotherapy for prostate cancer using modern techniques - 5-year tumor control and morbidity

Authors: Critz F.A.1; Williams W.H.; Holladay C.T.; Levinson A.K.; Benton J.B.; Holladay D.A.; Schnell F.J.; Maxa L.S.; Shrake P.D.

Source: Urology, Volume 54, Number 6, December 1999 , pp. 968-971(4)

Publisher: Elsevier

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Language: English

Document Type: Research article

DOI: 10.1016/S0090-4295(99)00346-5

Affiliations: 1: aRadiotherapy Clinics of Georgia, Decatur, Georgia, USA

This article is hosted on another website.

You may be required to register, activate a subscription or purchase the article before you can obtain the full text.

Proceed

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A